bluebird bio Inc (NAS:BLUE)
$ 0.6078 0.0338 (5.89%) Market Cap: 117.15 Mil Enterprise Value: 240.30 Mil PE Ratio: 0 PB Ratio: 0.29 GF Score: 25/100

Q1 2020 bluebird bio Inc Earnings Call Transcript

May 11, 2020 / 12:00PM GMT
Release Date Price: $38.99 (+1.60%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the bluebird bio First Quarter 2020 Earnings Conference Call. (Operator Instructions)

I would now like to hand the conference over to Ingrid Goldberg. Thank you. Please go ahead.

Ingrid Goldberg
bluebird bio, Inc. - VP of IR

Thank you, and good morning, everyone. This is Ingrid Goldberg, Investor Relations at bluebird bio, and welcome to today's conference call to discuss our quarterly earnings and the business update. I'm joined today by several members of the bluebird management team.

The format of today's call will be opening remarks from Nick, a sickle cell disease regulatory update from Dave, and we will complete the call with highlights from our revised operating plan from Chip. We will then turn to your questions.

Before we begin, I would like to remind everyone that our discussion today includes forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on our current expectations and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot